Energenesis BiomedicalLTD Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Energenesis BiomedicalLTD has a total shareholder equity of NT$726.2M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$753.7M and NT$27.5M respectively.
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
NT$0
Schuld
| Rente dekkingsratio | n/a |
| Contant | NT$631.70m |
| Aandelen | NT$726.21m |
| Totaal verplichtingen | NT$27.48m |
| Totaal activa | NT$753.69m |
Analyse van de financiële positie
Kortlopende schulden: 6657's short term assets (NT$653.3M) exceed its short term liabilities (NT$24.4M).
Langlopende schulden: 6657's short term assets (NT$653.3M) exceed its long term liabilities (NT$3.1M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 6657 is debt free.
Schuld verminderen: 6657 has no debt compared to 5 years ago when its debt to equity ratio was 5.7%.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: 6657 has sufficient cash runway for more than a year based on its current free cash flow.
Voorspelling contante baan: 6657 has sufficient cash runway for 2.2 years if free cash flow continues to reduce at historical rates of 20.8% each year.